Literature DB >> 28098579

XEN Gel Stent Internal Ostium Occlusion: Ab-Interno Revision.

Nuno Pinto Ferreira1, Luis Abegão Pinto, Carlos Marques-Neves.   

Abstract

Minimally invasive glaucoma surgery aims to provide a safer and less-invasive means of reducing IOP compared with traditional surgery, with the goal of reducing the need for topical medications. The XEN gel stent is an ab-interno minimally invasive glaucoma surgery device that approaches intraocular pressure reduction by creating a subconjunctival drainage pathway. As with any new device there is lack of experience and knowledge about its long-term results in terms of efficacy, technique, and complications. We report a clinical case of a XEN blood clot internal ostium obstruction and how it was managed. The ab-interno approach with microforceps seems a minimally invasive, safe, and effective procedure.

Entities:  

Mesh:

Year:  2017        PMID: 28098579     DOI: 10.1097/IJG.0000000000000625

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  Identifying the predictors of needling after XEN gel implant.

Authors:  Neha Midha; Harsha L Rao; André Mermoud; Kaweh Mansouri
Journal:  Eye (Lond)       Date:  2018-09-11       Impact factor: 3.775

2.  SUBCONJUNCTIVAL FRAGMENTATION OF A PREVIOUSLY EFFICIENT XEN GEL STENT IMPLANTATION AND SUCCESSFUL BLEB FORMATION: A CASE REPORT.

Authors:  Katia Novak-Lauš; Lana Knežević; Goran Marić; Mia Zorić Geber; Zoran Vatavuk
Journal:  Acta Clin Croat       Date:  2019-12       Impact factor: 0.780

3.  Ethics of Glaucoma Widgets.

Authors:  Tanuj Dada; Priyanka Ramesh; Anin Sethi; Shibal Bhartiya
Journal:  J Curr Glaucoma Pract       Date:  2020 Sep-Dec

4.  Xen45 gel stent ab interno trimming for ostium occlusion: case report.

Authors:  Filippo Tatti; Pietro Gentile; Lorenzo Mangoni; Giuseppe Demarinis; Pietro Napoli; Maurizio Fossarello
Journal:  BMC Ophthalmol       Date:  2021-12-27       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.